Novel approaches to screening guanidine derivatives

Bibliography

• Saczewski F, Balewski L. Biological activities of guanidine compounds. Expert Opin Ther Patents 2009;19:1417-48
   PubMed Web of Science ®Google Scholar
• Saczewski F, Balewski L. Biological activities of guanidine compounds, 2008–2012 update. Expert Opin Ther Patents 2013;23(8):965-95
   PubMed Web of Science ®Google Scholar
• Berlinck RGS, Burtoloso ACB, Kossuga MH. The chemistry and biology of organic guanidine derivatives. Nat Prod Rep 2008;25:919-54
   PubMed Web of Science ®Google Scholar
• Berlinck RGS, Burtoloso ACB, Trindade-Silva AE, et al. The chemistry and biology of organic guanidine derivatives. Nat Prod Rep 2010;27:1871-907
   PubMed Web of Science ®Google Scholar
• Castagnolo D, Schenone S, Botta M. Guanylated diamines, triamines, and polyamines: chemistry and biological properties. Chem Rev 2011;111:5247-300
   PubMed Web of Science ®Google Scholar
• Rauws TRM, Maes BUW. Transition metal-catalyzed N-arylations of amidines and guanidines. Chem Soc Rev 2012;41:2463-97
   PubMed Web of Science ®Google Scholar
• Patai S, Rappoport Z. The chemistry of amidines and imidinates. Volume 2. Wiley; New York: 1991
   Google Scholar
• Himmel H.-J. Guanidinyl-Functionalized Aromatic Compounds (GFAs) – charge and spin density studies as starting points for the development of a new class of redox-active ligands. Z Anorg Allg Chem 2013;639(11):1940-52
   Web of Science ®Google Scholar
• Bailey PJ, Pace S. The coordination chemistry of guanidines and guanidinates. Coord Chem Rev 2001;214:91-141
   Web of Science ®Google Scholar
• Coles MP. Bicyclic-guanidines, -guanidates and -guanidinium salts: wide ranging applications from a simple family of molecules. Chem Commun 2009;3659-76
   PubMed Web of Science ®Google Scholar
• Taylor JE, Bull SD, Williams MJ. Amidines, isothioureas, and guanidines as nucleophilic catalysts. Chem Soc Rev 2012;41:2109-21
   PubMed Web of Science ®Google Scholar
• Shao J, Chen W, Giulianotti MA, et al. Palladium-catalyzed C-H functionalization using guanidine as a directing group: ortho arylation and olefination of arylguanidines. Org Lett 2012;14:5452-5
   PubMed Web of Science ®Google Scholar
• Xing H, Zhang Y, Lai Y, et al. Synthesis of symmetrical and unsymmetrical N,N′-diaryl guanidines via copper/N-methylglycine-catalyzed arylation of guanidine nitrate. J Org Chem 2012;77:5449-53
   PubMed Web of Science ®Google Scholar
• Santana AG, Francisco CG, Suarez E, et al. Synthesis of guanidines from azides: a general and straightforward methodologyin carbohydrate chemistry. J Org Chem 2010;75:5371-4
   PubMed Web of Science ®Google Scholar
• Cooley CB, Trantow BM, Nederberg F, et al. Oligocarbonate molecular transporters: oligomerization-based syntheses and cell-penetrating studies. J Am Chem Soc 2009;131:16401-3
   PubMed Web of Science ®Google Scholar
• Hamilton SK, Harth E. Molecular dendritic transporter nanoparticle vectors provide efficient intracellular delivery of properties. ACS Nano 2009;3:402-10
   PubMed Web of Science ®Google Scholar
• Bagnacani V, Franceschi V, Fantuzzi L, et al. Lower rim guanidinocalix[4]arenes: macrocyclic nonviral vectors for cell transfection. Bioconjug Chem 2012;23:993-1002
   PubMed Web of Science ®Google Scholar
• Sun J, Miller JM, Beig A, et al. Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidine functionality. Expert Opin Drug Metab Toxicol 2011;7:313-23
   PubMed Web of Science ®Google Scholar
• Clark JF. editor. Guanidino compounds in biology and medicine (Developments in molecular and cellular biochemistry). Springer Science+Business Media; New York: 2003
   Google Scholar
• Heys L, Moore CG, Murphy PJ. The guanidine metabolites of Ptilocaulis spiculifer and related compounds; isolation and synthesis. Chem Soc Rev 1999;29:57-67
   Web of Science ®Google Scholar
• Dugas H, Schmidtchen FP, editors. Bioorganic chemistry frontiers (Chapter 6. The Guanidinium Group: Its Biological Role and Synthetic Analogs). Springer-Verlag GmbH; Berlin Heidelberg: 1993
   Google Scholar
• Convention on the prohibition of the development, production, stockpiling and use of chemical weapons and on their destruction. OPCW 2000:52
   Google Scholar
• Berlinck RGS, Kossuga MH. Natural guanidine derivatives. Nat Prod Rep 2005;22:516-50
   PubMed Web of Science ®Google Scholar
• Berlinck RGS. Natural guanidine derivatives. Nat Prod Rep 2002;19:617-49
   PubMed Web of Science ®Google Scholar
• Berlinck RGS. Natural guanidine derivatives. Nat Prod Rep 1999;16:339-65
   Web of Science ®Google Scholar
• Berlinck RGS. Natural guanidine derivatives. Nat Prod Rep 1996;13:377-409
   PubMed Web of Science ®Google Scholar
• Berlinck RGS. Fortschritte der Chemie Organischer. Naturstoffe 1995;66:119-295
   PubMedGoogle Scholar
• Kobayashi J, Ishibashi M. Comprehensive natural products chemistry, marine natural products and marine chemical ecology. Barton D & Nakanishi K. editors. Volume 8. 1999. p. 415-59
   Google Scholar
• Kobayashi J, Ishibashi M. The alkaloids, marine alkaloids II. Brossi A & Cordell GA. editors. Volume 41. 1992. p. 41-160
   Google Scholar
• Fattorusso E, Taglialatela-Scafati O. Modern alkaloids. Wiley-VCH Verlag GmbH; Weinheim: 2007
   Google Scholar
• Faulkner DJ. Marine natural products. Nat Prod Rep 1993;10:497-539
   PubMed Web of Science ®Google Scholar
• Christopherson C. Marine Alkaloids. In: Brossi A, editor. The alkaloids; chemistry and pharmacology. Volume 24. Academic Press; New York: 1985. p. 25-111
   Google Scholar
• Faulkner DJ. Marine natural products. Nat Prod Rep 1999;16:155-98
   Web of Science ®Google Scholar
• Van Soest RWM, Braekman JC, Faulkner DJ, et al. The genus Batzella: a chemosystematic problem. Bull Inst R Sci Nat Belg Biol 1996;66:89-101
   Google Scholar
• Kashman Y, Hirsh S, McConnell OJ, et al. Ptilomycalin A: a novel polycyclic guanidine alkaloid of marine origin. J Am Chem Soc 1989;111:8925-6
   Web of Science ®Google Scholar
• Jares-Erijman EA, Ingrum AL, Carney JR, et al. Polycyclic guanidine-containing compounds from the Mediterranean sponge Crambe crambe: the structure of 13,14,15-isocrambescidin 800 and the absolute stereochemistry of the pentacyclic guanidine moieties of the crambescidins. J Org Chem 1993;58:4805-8
   Web of Science ®Google Scholar
• Braekman JC, Daloze D, Tavares R, et al. Novel polycyclic guanidine alkaloids from two marine sponges of the genus monanchora. J Nat Prod 2000;63:193-6
   PubMed Web of Science ®Google Scholar
• Patil AD, Kumar NV, Kokke WC, et al. Novel Alkaloids from the Sponge Batzella sp.: inhibitors of HIV gp120-Human CD4 Binding. J Org Chem 1995;60:1182-8
   Web of Science ®Google Scholar
• Patil AD, Freyer AJ, Taylor PB, et al. Batzelladines F−I, Novel Alkaloids from the Sponge Batzella sp.: inducers of p56lck-CD4 Dissociation. J Org Chem 1997;62:1814-19
   Web of Science ®Google Scholar
• Calderón F, Wilson DM, Gamo F.-J., et al. Antimalarial drug discovery: recent progress and future directions. Prog Med Chem 2013;52:97-151
   Google Scholar
• Greenhill JV, Lue P. 5 amidines and guanidines in medicinal chemistry. Prog Med Chem 1993;30:203-326
   PubMedGoogle Scholar
• Hruby VJ. Designing peptide receptor agonists and antagonists. Nat Rev 2002;1:847-58
   Google Scholar
• Adessi C, Soto C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 2002;9:963-78
   PubMed Web of Science ®Google Scholar
• Dempcy RO, Almarsson O, Bruice TC. Design and synthesis of deoxynucleic guanidine: a polycation analogue of DNA. Proc Natl Acad Sci USA 1994;91:7864-8
   PubMed Web of Science ®Google Scholar
• Crooke ST. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J 1993;7:533-9
   PubMed Web of Science ®Google Scholar
• Price MLP, Guida WC, Jackson TE. Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model. Bioorg Med Chem Lett 2003;13:107-10
   PubMed Web of Science ®Google Scholar
• Bouaicha N, Amade P, Puel D, et al. A new cytotoxic guanidine alkaloid from the mediterranean sponge anchinoe-paupertas. J Nat Prod 1994;57(10):1455-7
   PubMed Web of Science ®Google Scholar
• Routier S, Bernier JL, Catteau JP, et al. Synthesis, DNA binding, topoisomerase II inhibition and cytotoxicity of two guanidine-containing anthracene-9,10-diones. Anti-Cancer Drug Des 1998;13(5):407-15
   PubMedGoogle Scholar
• Doebler JA. Gramicidin toxicity in NG108-15 cells: protective effects of acetamidine and guanidine. Cell Biol Toxicol 1999;15(5):279-89
   PubMed Web of Science ®Google Scholar
• Lundh L, Theslef S. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals. Eur J Pharmacol 1977;42:411-22
   PubMed Web of Science ®Google Scholar
• Lundh L, Leander S, Theslef S. Antagonism of the paralysis produced by botulinum toxin in the rat. The efects of tetraethylammonium, guanidine and 4-aminopyridine. J Neurol Sci 1977;32:29-43
   PubMed Web of Science ®Google Scholar
• Brzozowski Z, Saczewski F, Gdaniec M. Synthesis, molecular structure and anticancer activity of 1-allyl-3-amino-2-(4-chloro-2-mercaptobenzenesulphonyl) guanidine derivatives. Eur J Med Chem 2002;37(4):285-93
   PubMed Web of Science ®Google Scholar
• Kamal A, Ramesh G, Srinivas O, et al. Synthesis and antitumour activity of pyrene-linked pyrrolo [2,1-c][1,4]benzodiazepine hybrids. Bioorg Med Chem Lett 2004;14:471-4
   PubMed Web of Science ®Google Scholar
• Banik BK, Becker FF. Synthesis, electrophilic substitution and structure-activity relationship studies of polycyclic aromatic compounds towards the development of anticancer agents. Curr Med Chem 2001;8:1513-33
   PubMed Web of Science ®Google Scholar
• Bair KW, Tuttle RL, Knick VC, et al. (1-Pyrenylmethyl)Amino alcohols, a New class of antitumor DNA Intercalators - discovery and initial amine side-chain structure activity studies. J Med Chem 1990;33:2385-93
   PubMed Web of Science ®Google Scholar
• Bair KW, Andrews CW, Tuttle RL, et al. 2-[(Arylmethyl)Amino]-2-Methyl-1,3-Propanediol DNA Intercalatorss an examination of the effects of aromatic ring variation on antitumor-activity and DNA-binding. J Med Chem 1991;34:1983-90
   PubMed Web of Science ®Google Scholar
• Ohara K, Smietana M, Restouin A, et al. Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities. J Med Chem 2007;50(26):6465-75
   PubMed Web of Science ®Google Scholar
• Zhang X, Bruice TC. Complexation of single strand telomere and telomerase RNA template polyanions by deoxyribonucleic guanidine (DNG) polycations: plausible anticancer agents. Bioorg Med Chem Lett 2008;15:18
   Google Scholar
• Dolzhenko AV, Foo MC, Tan BJ, et al. Synthesis and Hererocyclizations of 3,4-Dihydroquinazolin-2-yl guanidine in the search of New Anticancer agents. Heterocycles 2009;78(7):1761-75
   Web of Science ®Google Scholar
• Makeeva AV, Popova TN, Sukhoveeva OV, et al. Effects of guanidine derivatives on the activities of superoxide dismutase and catalase during postischemic reperfusion in the rat brain. Neurochem J 2010;4(3):217-21
   Google Scholar
• Qian Y, Zhang H-J, Lv P-C, et al. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents. Biorg Med Chem 2010;18(23):8218-25
   PubMed Web of Science ®Google Scholar
• Ferreira EG, Wilke DV, Jimenez PC, et al. Guanidine alkaloids from monanchora arbuscula: chemistry and antitumor potential. Chem Biodivers 2011;8(8):1433-45
   Web of Science ®Google Scholar
• Makarieva TN, Tabakmaher KM, Guzii AG, et al.Monanchocidins B-E: polycyclic guanidine alkaloids with potent antileukemic activities from the sponge monanchora pulchra. J Nat Prod 2011;74(9):1952-8
   PubMed Web of Science ®Google Scholar
• Xie L, Zhao Y, Zhai X, et al. The application of Tandem Aza-Wittig reaction to synthesize artemisinin-guanidine hybrids and their anti-tumor activity. Arch Pharm 2011;344(10):631-8
   PubMed Web of Science ®Google Scholar
• Basu A, Sinha BN, Saiko P, et al. Effect of substitution at N''-position of N'-hydroxy-N-amino guanidines on tumor cell growth. Bioorg Med Chem Lett 2012;22(15):4934-8
   PubMed Web of Science ®Google Scholar
• He C, Fuchs MR, Ogata H, et al. Guanidine-Ferroheme coordination in the mutant protein nitrophorin 4(L130R). Angew Chem Int Ed 2012;51(18):4470-3
   PubMed Web of Science ®Google Scholar
• McKeever C, Kaiser M, Rozas I. Aminoalkyl derivatives of guanidine diaromatic minor groove binders with antiprotozoal activity. J Med Chem 2013;56(3):700-11
   PubMed Web of Science ®Google Scholar
• Stephens CE, Tanious F, Kim S, et al. Diguanidino and “Reversed” Diamidino 2,5-diarylfurans as antimicrobial agents. J Med Chem 2001;44:1741-8
   PubMed Web of Science ®Google Scholar
• Stephens CE, Brun R, Salem MM, et al. The activity of diguanidino and ‘reversed' diamidino 2,5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani. Bioorg Med Chem Lett 2003;13:2065-9
   PubMed Web of Science ®Google Scholar
• Arafa RK, Wenzler T, Brun R, et al. Molecular modeling study and synthesis of novel dicationic flexible triaryl guanidines and imidamides as antiprotozoal agents. Eur J Med Chem 2011;46:5852-60
   PubMed Web of Science ®Google Scholar
• Arafa RK, Ismail MA, Munde M, et al. Novel linear triaryl guanidines, N-substituted guanidines and potential prodrugs as antiprotozoal agents. Eur J Med Chem 2008;43:2901-8
   PubMed Web of Science ®Google Scholar
• Ahmed N, Brahmbhatt KG, Khan SI, et al. Synthesis and biological evaluation of tricyclic guanidine analogues of batzelladine K for antimalarial, antileishmanial, antibacterial, antifungal and anti-HIV activities. Chem Biol Drug Des 2013;81(4):491-8
   PubMed Web of Science ®Google Scholar
• Laville R, Thomas OP, Berrue F, et al. Bioactive guanidine alkaloids from two caribbean marine sponges. J Nat Prod 2009;72:1589-94
   PubMed Web of Science ®Google Scholar
• Reid CM, Ebikeme C, Barrett MP, et al. Synthesis of novel benzamidine- and guanidine-derived polyazamacrocycles: selective anti-protozoal activity for human African trypanosomiasis. Bioorg Med Chem Lett 2008;18:5399-401
   PubMed Web of Science ®Google Scholar
• Calas M, Ouattara M, Piquet G, et al. Potent antimalarial activity of 2-aminopyridinium salts, amidines, and guanidines. J Med Chem 2007;50:6307-15
   PubMed Web of Science ®Google Scholar
• Carte BK. Marine natural products as a source of novel pharmacological agents. Curr Opin Biotechnol 1993;4:275-9
   PubMedGoogle Scholar
• Christopherson C. Marine alkaloids. In: Brossi A, editor. The alkaloids; chemistry and pharmacology. Volume 24. Academic Press; New York: 1985. p. 25-111
   Google Scholar
• Patil AD, Kumar NV, Kokke WC, et al. Novel alkaloids from the sponge Batzella sp.: inhibitors of HIV gp l20-human CD4 binding. J Org Chem 1995;60:1182-8
   Web of Science ®Google Scholar
• Patil AD, Freyer AJ, Taylor PB, et al. Batzelladines F-I, novel alkaloids from the sponge Batzella sp.: inducers of p56lck-CD4 dissociation. J Org Chem 1997;62:1814-19
   Web of Science ®Google Scholar
• Chang LC, Whittaker NF, Bewley CA. Crambescidin 826 and Dehydrocrambine A:  new polycyclic guanidine alkaloids from the marine sponge Monanchora sp. that inhibit HIV-1 fusion. J Nat Prod 2003;66:1490-4
   PubMed Web of Science ®Google Scholar
• Bewley CA, Ray S, Cohen F, et al. Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues. J Nat Prod 2004;67(8):1319-24
   PubMed Web of Science ®Google Scholar
• Aquino CJ, Ramanjulu JM, Heyer D, et al. Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists. Bioorg Med Chem 2004;12(10):2691-708
   PubMed Web of Science ®Google Scholar
• Petersen HJ, Nielsen CK, Arrigoni-Martelli E. Synthesis and hypotensive activity of N-alkyl-N''-cyano-N'-pyridylguanidines. J Med Chem 1978;21:773-81
   PubMed Web of Science ®Google Scholar
• Bramm E, Ahnfelt-RBnne I, Arrigoni-Martelli E. Basic anti-inflammatory compounds. N,N',N''-Trisubstituted Guanidines. J Med Chem 1980;23:13-20
   PubMed Web of Science ®Google Scholar
• Sakai R, Higa T. Tubastrine, a new guanidinostyrene from the coral tubastrea aurea. Chem Lett 1987;127-8
   Web of Science ®Google Scholar
• Barenbrock JS, Köck M. Screening enzyme-inhibitory activity in several ascidian species from Orkney Islands using protein tyrosine kinase (PTK) bioassay-guided fractionation. J Biotechnol 2005;117:225-32
   PubMed Web of Science ®Google Scholar
• Short JH, Biermacher U, Dunnigan DA, et al. Sympathetic nervous system blocking agents. Derivatives of guanidine and related compounds. J Med Chem 1963;6:275-83
   PubMed Web of Science ®Google Scholar
• Pearce AN, Chia EW, Berridge MV, et al. Orthidines A–E, tubastrine, 3,4-dimethoxyphenethyl-beta-guanidine, and 1,14-sperminedihomovanillamide: potential anti-inflammatory alkaloids isolated from the New Zealand ascidian Aplidium orthium that act as inhibitors of neutrophil respiratory burst. Tetrahedron 2008;64:5748-55
   Web of Science ®Google Scholar
• Dambrova M, Zvejniece L, Skapare E, et al. The anti-inflammatory and antinociceptive effects of NF-kappaB inhibitory guanidine derivative ME10092. Int Immunopharmacol 2010;10:455-60
   PubMed Web of Science ®Google Scholar
• Cheng X, Wang J, Xia N, et al. A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation. EMBO Mol Med 2012;4:1112-25
   Google Scholar
• Shirota H, Gursel M, Klinman DM. Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling. J Immunol 2004;173:5002-7
   PubMed Web of Science ®Google Scholar
• Cheng X, Chen Y, Xie JJ, et al. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance. J Mol Cell Cardiol 2008;45:168-75
   PubMed Web of Science ®Google Scholar
• Chen PL, Chen JT, Lu DW, et al. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients. J Ocul Pharmacol Ther 2006;22:182-7
   PubMed Web of Science ®Google Scholar
• Bhekar RH, Jain MR, Goel A, et al. Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines. Bioorg Med Chem 2007;15:3248-65
   PubMed Web of Science ®Google Scholar
• Cafieri F, Fattorusso E, Mangani A, et al. Dispacamides, anti-histamine alkaloids from Caribbean Agelas sponges. Tetrahedron Lett 1996;37:3587-90
   Web of Science ®Google Scholar
• Hensler ME, Bernstein G, Nizet V, et al. Pyrrolidine bis-cyclic guanidines with antimicrobial activity against drug-resistant Gram-positive pathogens identified from a mixture-based combinatorial library. Bioorg Med Chem Lett 2006;16:5073-9
   PubMed Web of Science ®Google Scholar
• Kratzer C, Tobudic S, Graninger W, et al. In vitro antimicrobial activity of the novel polymeric guanidine Akacid plus. J Hosp Infect 2006;63:316-22
   PubMed Web of Science ®Google Scholar
• Qian L, Guan Y, He B, et al. Modified guanidine polymers: synthesis and antimicrobial mechanism revealed by AFM. Polymer (Guildf) 2008;49:2471-5
   Web of Science ®Google Scholar
• Cherouvrier J, Carreaux F, Bazureau JP. Microwave-mediated solventless synthesis of new derivatives of marine alkaloid Leucettamine B. Tetrahedron Lett 2002;43:3581-4
   Web of Science ®Google Scholar
• Mavar-Manga H, Haddad M, Pieters L, et al. Anti-inflammatory compounds from leaves and root bark of Alchornea cordifolia (Schumach. & Thonn.) Müll. Arg J Ethnopharmacol 2008;115:25-9
   PubMed Web of Science ®Google Scholar
• Ishikawa T. editor. Superbases for organic synthesis: guanidines, amidines, phosphazenes and related organocatalysts (Chapter 10. Amidines and Guanidines in Natural Products and Medicines). John Wiley & Sons, Ltd; UK: 2009
   Google Scholar
• Berber H, Mirand C, Derouin F. Selective synthesis of fluorinated benzyl- or phenylpyrimidines from the heterocyclisation of alpha-trifluoroacetylarylpropanenitriles. J Fluorine Chem 2007;128(9):1039-45
   Web of Science ®Google Scholar
• Cheam AL, Barr I, Mosse J, et al. Critical issues in vascular tissue engineering. Int Congr Ser 2004;1263:122-5
   Google Scholar
• Chand P, Kotian PL, Morris PE, et al. Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase. Bioorg Med Chem 2005;13:2665-78
   PubMed Web of Science ®Google Scholar
• Larsen SD, Connell MA, Cudahy MM, et al. Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-Guanidinopropionic acid:  discovery of a novel aminoguanidinoacetic acid antidiabetic agent. J Med Chem 2001;44:1217-30
   PubMed Web of Science ®Google Scholar
• Weiss S, Keller M, Bernhardt G, et al. NG-Acyl-argininamides as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity Bioorg Med Chem. 2010;18:6292-304
   Google Scholar
• O'Connor P, Atwal K, Li C, et al. Synthesis and evaluation of acylguanidine FXa inhibitors. Bioorg Med Chem Lett 2008;18:4696-9
   PubMed Web of Science ®Google Scholar
• Frederick R, Charlier C, Robert S, et al. Investigation of mechanism-based thrombin inhibitors: implications of a highly conserved water molecule for the binding of coumarins within the S pocket. Bioorg Med Chem Lett 2006;16:2017-21
   PubMed Web of Science ®Google Scholar
• Jain M, Bruice CT. Solid-phase synthesis of positively charged deoxynucleic guanidine (DNG) oligonucleotide incorporating 7-deazaguanine bases. Bioorg Med Chem 2006;14:7333-46
   PubMed Web of Science ®Google Scholar
• Ujjinamatada KR, Baier A, Borowski P, et al. An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: Synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-d-ribofuranoside. Bioorg Med Chem Lett 2007;17:2285-8
   PubMed Web of Science ®Google Scholar
• Igel P, Schneider E, Schnell D, et al. NG-Acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the NG-substituent. J Med Chem 2009;52:2623-7
   PubMed Web of Science ®Google Scholar
• Igel P, Geyer R, Strasser A, et al. Synthesis and structure−activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists. J Med Chem 2009;52:6297-313
   PubMed Web of Science ®Google Scholar
• Kraus A, Ghorai P, Birnkammer T, et al. NG-Acylated aminothiazolylpropyl guanidines as potent and selective histamine H2 receptor agonists. ChemMedChem 2009;4:232-40
   PubMed Web of Science ®Google Scholar
• Ghorai P, Kraus A, Keller M, et al. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. J Med Chem 2008;51:7193-204
   PubMed Web of Science ®Google Scholar
• Keller M, Teng S, Bernhardt G, et al. Bivalent argininamide-type neuropeptide YY1 antagonists do not support the hypothesis of receptor dimerisation. Chem Med Chem 2009;4:1733-45
   Google Scholar
• Weiss S, Keller M, Bernhardt G, et al. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists. Bioorg Med Chem 2008;16:9858-66
   PubMed Web of Science ®Google Scholar
• Keller M, Pop N, Hutzler C, et al. Guanidine−acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled NG-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide YY1 receptor antagonist. J Med Chem 2008;51:8168-72
   PubMed Web of Science ®Google Scholar
• Schneider E, Keller M, Brennauer A, et al. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist. ChemBioChem 2007;8:1981-8
   PubMed Web of Science ®Google Scholar
• Lee S, Yi KY, Youn SJ, et al. (2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors. Bioorg Med Chem Lett 2009;19:1329-31
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Lavin RC, Thakker PM, et al. Solution-Phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers. Bioorg Med Chem Lett 2001;11:3151-5
   PubMed Web of Science ®Google Scholar
• Liu YH, Cao LH. Synthesis and bioactivity of novel methyl 6-deoxy-6-(N′-alkyl/aryl-N″-benzothiazol-2-yl)guanidino-alpha-d-glucopyranosides. Carbohydr Res 2008;343:615-25
   PubMed Web of Science ®Google Scholar
• Singh AR, Joshi S, Arya R, et al. Guanidine hydrochloride and urea-induced unfolding of Brugia malayi hexokinase. Eur Biophys J 2010;39:289-97
   PubMed Web of Science ®Google Scholar
• Gerritz SW, Zhai W, Shi S, et al. Acyl Guanidine inhibitors of beta-Secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesis. J Med Chem 2012;55:9208-23
   PubMed Web of Science ®Google Scholar
• Murtaza G, Rauf MK, Badshah A, et al. Synthesis, structural characterization and in vitro biological screening of some homoleptic copper(II) complexes with substituted guanidines. Eur J Med Chem 2012;48:26-35
   PubMed Web of Science ®Google Scholar
• Gul R, Khan A, Badshah A, et al. A new supramolecular ferrocenyl phenylguanidines as potent antimicrobial and DNA-binding agents. J Coord Chem 2013;66(11):1959-73
   Web of Science ®Google Scholar
• Murtaza G, Badshah A, Said M, et al. Urease inhibition and anti-leishmanial assay of substituted benzoylguanidines and their copper(II) complexes. Dalton Trans 2011;40:9202-11
   PubMed Web of Science ®Google Scholar